Encore Medical, Inc. (EMI)

Encore Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2024	Dec 31, 2023
Cash & Equivalents	0.05	0.25	0.31
Cash & Cash Equivalents	0.05	0.25	0.31
Cash Growth	-	-19.14%	-
Receivables	0.47	0.35	0.38
Inventory	-	0.37	0.47
Other Current Assets	0.41	0.04	0.03
Total Current Assets	0.94	1.01	1.18
Property, Plant & Equipment	-	0.04	0.04
Goodwill and Intangibles	-	0.4	0.47
Other Long-Term Assets	-	-0	0
Total Long-Term Assets	-	0.44	0.51
Total Assets	-	1.45	1.69
Accounts Payable	-	0.42	0.09
Current Debt	-	0.12	0.11
Other Current Liabilities	-	0.47	0.24
Total Current Liabilities	-	1.01	0.43
Long-Term Debt	-	1.35	1.42
Other Long-Term Liabilities	-	-0	-0
Total Long-Term Liabilities	-	1.35	1.42
Total Liabilities	-	2.36	1.85
Total Debt	1.55	1.47	1.53
Debt Growth	-	-3.90%	-
Retained Earnings	-	-5.89	-4.04
Shareholders' Equity	-0.99	-0.91	-0.16
Net Cash (Debt)	-1.5	-1.22	-1.23
Working Capital	0.94	-0	0.74

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).